AMRX · Amneal Pharmaceuticals, Inc. · Documents
$20.38
-0.10 (-0.49%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$6.51B
Shares
319.35M
Volume · Oct 23
4.93M
Avg daily vol (3M)
2.67M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2021-11-08 | 2021-09-30 | |
| 8-K | — | 2021-11-03 | — | |
| 8-K | — | 2021-08-09 | — | |
| 10-Q | — | 2021-08-09 | 2021-06-30 | |
| 8-K | — | 2021-05-10 | 2021-05-05 | |
| 10-Q | — | 2021-05-07 | 2021-03-31 | |
| 8-K | — | 2021-05-07 | — | |
| 8-K | — | 2021-04-05 | 2021-04-02 | |
| DEFA14A | — | 2021-03-24 | — | |
| DEF 14A | — | 2021-03-24 | 2021-05-05 | |
| PRE 14A | — | 2021-03-08 | 2021-05-05 | |
| 10-K | — | 2021-03-01 | 2020-12-31 | |
| 8-K | — | 2021-02-26 | — | |
| 8-K | — | 2021-02-16 | 2021-02-12 | |
| 8-K | — | 2021-01-12 | — | |
| 8-K | — | 2020-12-18 | 2020-12-16 | |
| 10-Q | — | 2020-11-06 | 2020-09-30 | |
| 8-K | — | 2020-11-06 | — | |
| 10-Q | — | 2020-08-06 | 2020-06-30 | |
| 8-K | — | 2020-08-06 | — | |
| 8-K | — | 2020-08-04 | 2020-07-31 | |
| 8-K | — | 2020-05-11 | — | |
| 10-Q | — | 2020-05-11 | 2020-03-31 | |
| 8-K | — | 2020-05-08 | 2020-05-05 | |
| 8-K/A | — | 2020-04-17 | 2020-01-31 | |
| DEFA14A | — | 2020-04-15 | — | |
| DEFA14A | — | 2020-03-23 | — | |
| DEF 14A | — | 2020-03-23 | 2020-05-05 | |
| 8-K | — | 2020-03-12 | 2020-03-11 | |
| 10-K | — | 2020-03-02 | 2019-12-31 | |
| 8-K | — | 2020-02-26 | — | |
| 8-K | — | 2020-02-26 | 2020-02-20 | |
| 8-K/A | — | 2020-02-20 | 2019-08-02 | |
| 8-K/A | — | 2020-02-20 | 2019-12-14 | |
| 8-K | — | 2020-02-04 | 2020-01-31 | |
| 8-K | — | 2020-01-15 | — |
Showing 101–136 of 136 filings
Key facts
CIK
1723128
CUSIP
03168L105
13F (30d)
70 filings
66 filers
Visit website
Investor relations